Gabrielle Masson
Fierce journalist and industry analyst focused on pharmaceutical and biotech business news, contributing expert commentary on anticipated drug launches and market forecasts.
Best podcasts with Gabrielle Masson
Ranked by the Snipd community
6 snips
Feb 6, 2026 • 13min
The biggest potential drug launches of 2026
Gabrielle Masson, Fierce journalist and industry analyst covering pharma and biotech business news. She discusses the massive sales forecasts for next-generation obesity drugs from Novo Nordisk and Eli Lilly. Short takes cover the methodology behind the annual launches list, comparisons with prior years, and a roundup of other 2026 candidates across cancer, myeloma, inflammation, kidney disease and essential tremor.
